Agenus reported $-228843000 in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Amgen AMGN:US $ 8217M 30M
AstraZeneca AZN:LN 39744M 24068M
Bristol Myers Squibb BMY:US $ 37213M 405M
Celldex Therapeutics CLDX:US $ 436.71M 254.43M
Chemocentryx CCXI:US $ 315.89M 14.38M
CSL CSL:AU $ 8.38B 227M
Dicerna Pharmaceuticals DRNA:US $ 107.66M 3.41M
Dynavax Technologies DVAX:US $ 67.58M 15.8M
Eli Lilly And LLY:US $ 7757M 1312.6M
Flexion Therapeutics FLXN:US $ -82377000 26.21M
Genocea Biosciences GNCA:US $ 37.83M 33.77M
Gilead Sciences GILD:US $ 21471M 1768M
Glaxosmithkline GSK:US $ 15426M 49M
GlaxoSmithKline GSK:LN 15426M 49M
Immunogen IMGN:US $ 77.09M 8.63M
Intrexon XON:US $ 131.25M 27.95M
Jiangsu Hengrui Me. 600276:CH CH 34.24B 1.45B
Karyopharm Therapeutics KPTI:US $ -125977000 42.84M
Macrogenics MGNX:US $ 291.44M 27.61M
Merck MRK:GR € 20607M 1314M
Northwest Biotherapeutics NWBO:US -301733000 48.11M
Novartis NOVN:VX SF 56771M 2729M
Novavax NVAX:US $ 461.34M 284.23M
Regeneron Pharmaceuticals REGN:US $ 17258M 2130.7M
Rigel Pharmaceuticals RIGL:US $ 49.67M 18.44M
Sangamo Biosciences SGMO:US $ 406.02M 39.44M
Veracyte VCYT:US $ 1107.08M 135.9M
YTE INCY:US $ 3148.66M 212.8M